# A Study on the Effect of Renal Function on the Pharmacakokinetics of RO5024048 (Parent of Prodrug RO5024048) Following Multiple Oral Dose Administration of RO5024048

> **NCT01099904** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** RO5024048

## Key facts

- **NCT ID:** NCT01099904
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099904, "A Study on the Effect of Renal Function on the Pharmacakokinetics of RO5024048 (Parent of Prodrug RO5024048) Following Multiple Oral Dose Administration of RO5024048". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01099904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*